AEPCX
Price
$56.85
Change
+$0.35 (+0.62%)
Updated
Jun 16 closing price
Net Assets
132.56B
RERAX
Price
$55.45
Change
+$0.35 (+0.64%)
Updated
Jun 16 closing price
Net Assets
132.56B
Interact to see
Advertisement

AEPCX vs RERAX

Header iconAEPCX vs RERAX Comparison
Open Charts AEPCX vs RERAXBanner chart's image
American Funds EUPAC C
Price$56.85
Change+$0.35 (+0.62%)
VolumeN/A
Net Assets132.56B
American Funds EUPAC R1
Price$55.45
Change+$0.35 (+0.64%)
VolumeN/A
Net Assets132.56B
AEPCX vs RERAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. RERAX commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX (133B) and RERAX (133B) have equal amount of cash in the bank . RERAX pays higher dividends than AEPCX: RERAX (0.42) vs AEPCX (0.32). AEPCX was incepted earlier than RERAX: AEPCX (24 years) vs RERAX (23 years). AEPCX (1.59) and RERAX (1.57) have similar cost to investors . AEPCX (30.00) and RERAX (30.00) have comparable annual turnover. AEPCX (250) and RERAX (250) have matching initial minimum investment requirements. AEPCX (4.09) and RERAX (3.94) have marching annual gain over last year. AEPCX (13.21) and RERAX (12.72) have equivalent 5 years return.
AEPCXRERAXAEPCX / RERAX
Total Expense Ratio1.591.57101%
Annual Report Gross Expense Ratio1.591.57101%
Fund Existence24 years23 years-
Gain YTD10.0259.954101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets133B133B100%
Annual Yield % from dividends0.320.4277%
Returns for 1 year4.093.94104%
Returns for 3 years25.6825.34101%
Returns for 5 years13.2112.72104%
Returns for 10 years16.7715.65107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT1.490.12
+8.76%
Galectin Therapeutics
SINT3.420.15
+4.59%
SiNtx Technologies Inc.
EPAM172.581.83
+1.07%
Epam Systems
TTGT7.130.06
+0.85%
TechTarget
PLMR162.301.37
+0.85%
Palomar Holdings